Jeroen Vanbrabant

Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer’s disease

Shorena Janelidze, Divya Bali, Nicholas J. Ashton et al. · Brain · 2022 · 505 citations · Full text

Life Sciences, Biochemistry, Dementia +16

Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology

Inge M.W. Verberk, Elisabeth H. Thijssen, Jannet Koelewijn et al. · Alzheimer s Research & Therapy · 2020 · 273 citations · Full text

Medicine, Neurology, Neuroscience +17

Plasma and CSF biomarkers in a memory clinic: Head‐to‐head comparison of phosphorylated tau immunoassays

Nicholas J. Ashton, Albert Puig‐Pijoan, Marta Milà‐Alomà et al. · Alzheimer s & Dementia · 2022 · 224 citations · Full text

Medicine, Neurology, Neuroscience +17

Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231

Sherif Bayoumy, Inge M.W. Verberk, Ben den Dulk et al. · Alzheimer s Research & Therapy · 2021 · 197 citations · Full text

Medicine, Geriatric Medicine, Dementia +13

Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease

Douglas Galasko, Mei-Fang Xiao, Desheng Xu et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2019 · 148 citations · Full text

Life Sciences, Neurology, Neuroscience +17